GIN4 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to GIN4 Antibody

GIN4 antibodies are polyclonal reagents raised against specific regions of the Gin4 protein, a member of the Nim1 kinase family. Gin4 is essential for septin assembly, mitotic control, and proper daughter cell growth during the G2/M phase . These antibodies are primarily used in molecular and cellular biology to:

  • Detect Gin4 expression levels in yeast strains .

  • Study Gin4’s interaction with septins and other regulatory proteins like Nap1 and Cdc14 .

  • Analyze Gin4 phosphorylation states during mitosis .

Development of GIN4 Antibodies

GIN4 antibodies are generated using recombinant fragments of the Gin4 protein. Key methods include:

  • Immunogen Design: A COOH-terminal fragment (residues 936 to stop codon) or a 6X-histidine-tagged fusion protein is used for immunization .

  • Antibody Purification: Affinity purification with maltose-binding protein (MBP) or glutathione S-transferase (GST) fusion proteins ensures specificity .

  • Validation: Specificity is confirmed via Western blotting in wild-type versus gin4Δ strains .

4.1. Septin Organization

Gin4 antibodies revealed that Gin4 is required for septin localization at the bud neck. In gin4Δ mutants, septins fail to form organized rings, leading to aberrant cell morphology .

4.2. Mitotic Regulation

Co-immunoprecipitation studies using GIN4 antibodies identified a mitotic complex containing Gin4, Nap1, Bni5, and septins. This complex facilitates Gin4 hyperphosphorylation and activation during mitosis .

4.3. Interaction with Cdc14

Gin4 antibodies helped demonstrate that the nucleolus-associating domain of Gin4 binds Cdc14, a phosphatase critical for mitotic exit. Deletion of this domain causes premature exit from mitosis .

Applications in Research

GIN4 antibodies are pivotal in studying:

  • Cell Cycle Checkpoints: Gin4’s role in the G2/M transition .

  • Septin Dynamics: How septins coordinate cytokinesis and cell polarity .

  • Protein Kinase Networks: Cross-talk between Gin4, Nap1, and other regulatory kinases .

Challenges and Limitations

  • Cross-Reactivity: Anti-GIN4 antibodies may recognize epitopes shared with other Nim1 kinases .

  • Strain Dependency: Results vary in yeast strains with septin mutations (e.g., cdc11Δ) .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
GIN4 antibody; YDR507C antibody; D9719.13 antibody; Serine/threonine-protein kinase GIN4 antibody; EC 2.7.11.1 antibody; Growth inhibitory protein 4 antibody
Target Names
GIN4
Uniprot No.

Target Background

Function
GIN4 Antibody targets a serine/threonine-protein kinase that regulates the localization and function of septins during mitosis. It specifically phosphorylates SHS1.
Gene References Into Functions
  1. GIN4 plays a crucial role in the precise control of membrane lipid asymmetry, which is essential for optimal cytokinesis. PMID: 25646086
  2. Research has demonstrated that GIN4 is required for the proper localization and in vivo activity of the budding yeast Bnr1 protein, in conjunction with the septin Shs1. PMID: 22918953
  3. The protein Elm1 acts as a regulator of septin assembly-dependent cellular processes by directly phosphorylating and activating the Gin4-dependent pathway. PMID: 16861226
Database Links

KEGG: sce:YDR507C

STRING: 4932.YDR507C

Protein Families
Protein kinase superfamily, CAMK Ser/Thr protein kinase family, NIM1 subfamily
Subcellular Location
Cytoplasm. Bud neck.

Q&A

What is GIN4 and why are GIN4 antibodies important in research?

GIN4 is a Nim1-related kinase in budding yeast that plays a critical role in septin localization and proper control of daughter cell growth during G2/M phase. The protein becomes hyperphosphorylated when cells enter mitosis, leading to activation of its kinase activity . GIN4 antibodies are important research tools because they allow for the detection, isolation, and characterization of GIN4 and its interaction partners. These antibodies enable researchers to investigate GIN4's role in cell cycle regulation, septin organization, and mitotic progression through techniques such as Western blotting, immunoprecipitation, and immunofluorescence microscopy.

How are GIN4 antibodies typically generated for research applications?

GIN4 antibodies are typically generated through either polyclonal or monoclonal approaches. Based on established protocols, researchers can create anti-GIN4 antibodies by:

  • Expressing full-length GIN4 or specific domains as fusion proteins (such as with maltose-binding protein or GST)

  • Purifying the fusion protein from bacterial expression systems

  • Immunizing rabbits or other host animals with the purified protein

  • Affinity purifying the resulting antibodies using columns containing immobilized GIN4 protein or fragments

For tagged versions of GIN4, researchers may also generate antibodies against the tag itself, such as HA-tag antibodies for HA-tagged GIN4 constructs. These antibodies can be generated by immunizing rabbits with HA peptides (e.g., CPDYAGYPYDVPDYAG) conjugated to carrier proteins like keyhole limpet hemocyanin .

What are the primary applications of GIN4 antibodies in research settings?

ApplicationPurposeKey Methodological Considerations
Western BlottingDetection of GIN4 expression levels and phosphorylation statesOptimize antibody dilution (typically 1:1000-1:5000); consider phosphatase treatment controls when studying phosphorylation
ImmunoprecipitationIsolation of GIN4 and associated protein complexesUse affinity-purified antibodies bound to protein A beads; include appropriate controls (anti-GST or anti-MBP antibodies)
ImmunofluorescenceVisualization of GIN4 localization in cellsFixation method critical; paraformaldehyde typically preferred; include peptide competition controls
Kinase AssaysAssessment of GIN4 activityImmunoprecipitate GIN4 using specific antibodies before performing kinase reactions

What are the optimal conditions for using GIN4 antibodies in immunoprecipitation experiments?

For optimal immunoprecipitation of GIN4 and its associated proteins, the following protocol has been demonstrated to be effective:

  • Prepare affinity-purified anti-GIN4 antibodies bound to protein A beads (approximately 5 μg of antibody per 20 μl of protein A beads)

  • Use a lysis buffer containing 50 mM HEPES-KOH (pH 7.6), 175 mM KCl, 75 mM NaF, 1 mM EGTA, 1 mM MgCl₂, 0.45% Tween-20, and 5% glycerol, supplemented with protease inhibitors

  • Incubate cell lysates with antibody-coupled beads for 1.5-2 hours at 4°C with gentle rotation

  • Wash the beads multiple times with lysis buffer containing 10% glycerol

  • Elute GIN4 and associated proteins using high salt conditions (e.g., 1 M KCl)

When studying mitotic complexes, it's advisable to synchronize cells using approaches such as benomyl treatment to arrest cells in mitosis for 2.5 hours before harvesting .

How can GIN4 antibodies be used to study the Gin4-septin complex?

GIN4 antibodies are valuable tools for investigating the Gin4-septin complex formation, which plays a crucial role in cell morphogenesis and cytokinesis. A methodological approach includes:

  • Immunoprecipitate GIN4 using anti-GIN4 antibodies as described above

  • Analyze co-precipitating proteins by Western blotting using antibodies against specific septins (e.g., anti-Shs1, anti-Cdc11)

  • To confirm direct interactions, perform reciprocal immunoprecipitations using septin antibodies

  • Include controls with non-specific antibodies to ensure specificity of the interactions

  • Consider using synchronized cell populations, as the Gin4-septin complex is cell cycle-dependent with peak formation during mitosis

Research has demonstrated that Gin4 associates with septin proteins during mitosis as part of a multiprotein complex that includes Nap1, Bni5, and the septins .

What controls should be included when using GIN4 antibodies for Western blotting?

When performing Western blotting with GIN4 antibodies, the following controls should be included:

  • Positive control: Lysate from wild-type cells known to express GIN4

  • Negative control: Lysate from gin4Δ deletion strains

  • Specificity control: Preincubation of the antibody with excess purified GIN4 protein (peptide competition)

  • Loading control: Probing for a housekeeping protein (e.g., actin, GAPDH)

  • Phosphorylation controls: When studying phosphorylation states, include samples treated with phosphatases

For tagged GIN4 constructs, additional controls should include untransfected cells and cells expressing the tag alone to distinguish GIN4-specific signals from background.

How can GIN4 antibodies be used to investigate hyperphosphorylation of GIN4 during mitosis?

The hyperphosphorylation of GIN4 during mitosis is a critical regulatory event that activates its kinase activity. To investigate this phenomenon using GIN4 antibodies:

  • Cell synchronization approach:

    • Arrest cells at different cell cycle stages (e.g., using α-factor for G1, hydroxyurea for S-phase, or benomyl for mitosis)

    • Harvest cells at different time points after release from arrest

    • Immunoprecipitate GIN4 using anti-GIN4 antibodies

    • Analyze phosphorylation by:

      • Mobility shift in SDS-PAGE

      • Phospho-specific antibodies if available

      • Mass spectrometry to identify specific phosphorylation sites

  • In vitro kinase assays:

    • Immunoprecipitate GIN4 from mitotic cells

    • Perform kinase assays using purified substrates (e.g., Shs1 septin)

    • Include controls with kinase-dead GIN4 mutants

Research has shown that GIN4 molecules present in mitotic complexes phosphorylate each other, leading to hyperphosphorylation, which can be detected as mobility shifts in SDS-PAGE analysis .

What are the technical considerations for using GIN4 antibodies to study protein-protein interactions?

When using GIN4 antibodies to study protein-protein interactions beyond the known Gin4-septin complex:

  • Immunoaffinity purification followed by mass spectrometry:

    • Create HA-tagged GIN4 constructs for enhanced purification

    • Use anti-HA antibodies with high specificity (e.g., those recognizing junctions between HA tags)

    • Elute complexes under native conditions to preserve interactions

    • Analyze by mass spectrometry to identify novel interaction partners

  • Proximity-dependent labeling:

    • Fuse GIN4 to a proximity labeling enzyme (BioID or TurboID)

    • Use GIN4 antibodies to confirm proper expression and localization

    • Identify labeled proteins as potential interaction partners

  • Co-immunoprecipitation validation:

    • For newly identified interactions, perform reverse co-immunoprecipitation

    • Use appropriate controls to rule out non-specific binding

    • Consider the impact of detergents on complex stability

MethodAdvantagesLimitationsKey Controls
Standard Co-IPPreserves native complexesMay miss weak/transient interactionsAnti-GST or anti-MBP antibodies as negative controls
Cross-linking Co-IPCaptures transient interactionsMay introduce artifactsNo-crosslinker control
Immunoaffinity PurificationHigher purity for MS analysisRequires tagged constructsMock purifications from untagged strains
Proximity LabelingDetects spatial proximity in vivoMay identify non-direct interactorsKinase-dead GIN4 constructs

How can I design experiments using GIN4 antibodies to investigate the kinase activity of GIN4?

To investigate GIN4 kinase activity using GIN4 antibodies:

  • Immunoprecipitation kinase assays:

    • Immunoprecipitate GIN4 using anti-GIN4 antibodies

    • Incubate immunoprecipitates with recombinant substrates (e.g., purified Shs1) and ATP

    • Detect phosphorylation by:

      • Autoradiography (using [γ-³²P]ATP)

      • Phospho-specific antibodies

      • Mass spectrometry

  • In-gel kinase assays:

    • Immunoprecipitate GIN4 and resolve by SDS-PAGE

    • Renature proteins in the gel

    • Incubate with kinase reaction buffer containing substrate and [γ-³²P]ATP

    • Detect activity by autoradiography

  • Identification of physiological substrates:

    • Immunoprecipitate GIN4 from wild-type and kinase-dead mutants

    • Identify differentially phosphorylated proteins by mass spectrometry

    • Validate with phospho-specific antibodies

Research has demonstrated that the Shs1 septin undergoes GIN4-dependent phosphorylation during mitosis and appears to be a substrate of GIN4 in vitro, suggesting it is a physiological target of GIN4 kinase activity .

What methodological approaches can be used to generate and validate phospho-specific GIN4 antibodies?

Generating phospho-specific GIN4 antibodies requires:

  • Identification of key phosphorylation sites:

    • Immunoprecipitate GIN4 from mitotic cells

    • Analyze by mass spectrometry to identify phosphorylation sites

    • Select sites with potential regulatory significance

  • Antibody generation:

    • Synthesize phosphopeptides corresponding to identified sites

    • Conjugate to carrier protein

    • Immunize rabbits or other host animals

    • Perform dual affinity purification:

      • First with phosphopeptide column to isolate phospho-reactive antibodies

      • Then with non-phosphopeptide column to remove antibodies that recognize non-phosphorylated epitopes

  • Validation approaches:

    • Western blotting comparing samples from wild-type and kinase-dead mutants

    • Dephosphorylation controls using lambda phosphatase treatment

    • Peptide competition assays with phospho and non-phospho peptides

    • Testing against GIN4 with mutagenized phosphorylation sites

How do I troubleshoot weak signals when using GIN4 antibodies in immunofluorescence?

When experiencing weak signals in immunofluorescence experiments with GIN4 antibodies:

  • Fixation optimization:

    • Test different fixation methods (paraformaldehyde, methanol, acetone)

    • Optimize fixation duration and temperature

    • Consider epitope retrieval methods if the antibody recognizes a conformational epitope

  • Antibody concentration:

    • Titrate antibody concentration over a wider range

    • Consider longer incubation times (overnight at 4°C)

    • Use signal amplification methods (tyramide signal amplification)

  • Blocking optimization:

    • Test different blocking agents (BSA, normal serum, commercial blockers)

    • Extend blocking time to reduce background

  • Detection system:

    • Use high-sensitivity secondary antibodies

    • Consider conjugated primary antibodies to eliminate secondary antibody variability

    • Try biotin-streptavidin amplification systems

  • Sample preparation:

    • For yeast cells, optimize spheroplasting conditions to improve antibody accessibility

    • Consider permeabilization optimization with different detergents

What are the challenges in using GIN4 antibodies across different yeast species or model organisms?

Using GIN4 antibodies across different species presents several challenges:

  • Epitope conservation:

    • Sequence divergence between orthologs may affect antibody recognition

    • Perform sequence alignment of GIN4 orthologs to identify conserved regions

    • Consider generating antibodies against highly conserved domains

  • Validation strategies:

    • Use knockout/knockdown controls in each species to confirm specificity

    • Perform Western blots to verify appropriate molecular weight detection

    • Consider testing recombinant GIN4 proteins from different species

  • Cross-reactivity testing:

    • Test antibodies against related kinases to assess specificity

    • Perform peptide competition assays with orthologous peptides

  • Alternative approaches:

    • When cross-reactivity is poor, consider generating species-specific antibodies

    • Alternatively, use epitope tagging approaches (HA, FLAG) and corresponding tag antibodies

    • For model organisms with poor GIN4 antibody recognition, consider using antibodies against conserved interaction partners

How can GIN4 antibodies be used in combination with new methodologies to study GIN4 dynamics?

Emerging methodologies that can be combined with GIN4 antibodies include:

  • Super-resolution microscopy:

    • Use highly specific GIN4 antibodies conjugated to bright fluorophores

    • Apply techniques like STORM, PALM, or SIM to visualize GIN4 localization at nanoscale resolution

    • Combine with septin antibodies for co-localization studies beyond diffraction limit

  • Live-cell imaging approaches:

    • Generate nanobodies derived from GIN4 antibodies for live-cell applications

    • Fuse nanobodies to fluorescent proteins for dynamic tracking

    • Compare fixed-cell antibody staining with live-cell dynamics

  • Spatial proteomics:

    • Use GIN4 antibodies for proximity labeling in specific cellular compartments

    • Combine with mass spectrometry to identify location-specific interaction partners

    • Compare interactomes across cell cycle stages

  • Antibody-based biosensors:

    • Develop FRET-based biosensors incorporating GIN4 antibody fragments

    • Monitor GIN4 conformational changes or phosphorylation states in real-time

    • Apply in live-cell imaging to correlate GIN4 activity with cellular events

These advanced methodologies can provide unprecedented insights into GIN4 function, localization, and regulation in both normal and perturbed cellular states.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.